Theradaptive Company
Theradaptive develops targeted therapeutics using its proprietary THX1 platform
Technology:
Other
Industry:
PharmTech
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2016-05-02
Employees Number:
1-10
Investors Number:
6
Total Funding:
$10.5M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership